Stocks and Investing Stocks and Investing
Wed, August 2, 2023

Phil Nadeau Maintained (VRTX) at Buy with Increased Target to $370 on, Aug 2nd, 2023


Published on 2024-10-28 05:22:44 - WOPRAI, Phil Nadeau
  Print publication without navigation


Phil Nadeau of TD Cowen, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $360 to $370 on, Aug 2nd, 2023.

Phil has made no other calls on VRTX in the last 4 months.



There are 11 other peers that have a rating on VRTX. Out of the 11 peers that are also analyzing VRTX, 2 agree with Phil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $325 on, Tuesday, May 2nd, 2023
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $340 on, Tuesday, May 2nd, 2023


These are the ratings of the 9 analyists that currently disagree with Phil


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $245 on, Tuesday, August 1st, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $424 on, Monday, July 24th, 2023
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $400 on, Friday, July 21st, 2023
  • Myles Minter of "William Blair" Initiated at Buy on, Tuesday, May 30th, 2023
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $385 on, Thursday, May 4th, 2023
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $400 on, Wednesday, May 3rd, 2023
  • Jessica Fye of "JP Morgan" Maintained at Buy and Held Target at $345 on, Tuesday, May 2nd, 2023
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $385 on, Tuesday, May 2nd, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $456 on, Tuesday, May 2nd, 2023

Contributing Sources